NCT00539630View on ClinicalTrials.gov

TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN

PHASE3CompletedINTERVENTIONAL

Enrollment

86

Participants

Timeline

Start Date

November 30, 2002

Conditions

Carcinoma, Squamous Cell

Interventions

DRUG

Docetaxel

Trial Locations (1)

Unknown

Sanofi-Aventis, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY